Global Oligonucleotide Synthesis Market Research Report: By Product (Oligonucleotide, Reagents and Equipment), By Type (Custom Oligos and Predesigned Oligos), By Application (Therapeutic Applications, Diagnostics, Research and others), By End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and others) - Forecast till 2027
ID: MRFR/LS/1721-HCR | February 2021 | Region: Global | 95 pages
Market Scenario
Oligonucleotide Synthesis Market is expected to register a CAGR of 7.2% during the forecast period of 2019 to 2027.
Oligonucleotides are little fragments of nucleic acids that are produced through enzymatic chemistry and genetic engineering. Oligonucleotides are primarily used in laboratories for diagnostics, academic and industrial, and therapeutic applications. Oligonucleotide synthesis occurs either commercially to deliver services for various end-users or individually through DNA synthesizers for self-consumption. Currently, successive enhancements in oligonucleotide synthesis, magnification, and automation have entirely revolutionized biological research. It is also feasible to do the customizations and get the essential sequence online easily and at the required time. These services fluctuate greatly by the cost of per base pair, error rates, lengths, and throughput, among others.
Segmentation
Global Oligonucleotide Synthesis Market has been segmented based on Product, Type, Application, End-User, and Region.
Global Oligonucleotide Synthesis Market, based on product, has been bifurcated into oligonucleotide, reagents, and equipment.
Based on type, the market is further segmented into custom oligos, predesigned oligos. The global oligonucleotide synthesis market, based on application, has been segmented into therapeutic applications, diagnostics, research, and others. On the basis of end-user, the market has been bifurcated into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and others.
The global oligonucleotide synthesis market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The oligonucleotide synthesis market in the Americas has further been branched into North America and Latin America; the North American market has been divided into the US and Canada. The European oligonucleotide synthesis market has been sub-divided into Western Europe and Eastern Europe. The market in Western Europe has further been divided into France, the UK, Germany, Italy, Spain, and the rest of Western Europe. The oligonucleotide synthesis market in Asia-Pacific has been segmented into India, South Korea, Japan, China, Australia, and the rest of Asia-Pacific. The oligonucleotide synthesis market in the Middle East & Africa has been divided into the Middle East and Africa.
Key Players
The Key Players in the Global Oligonucleotide Synthesis Market are Thermo Fisher Scientific, Inc., Adtbio, Merck - Co., Inc., Bio-Synthesis Inc., Eurofins Genomics, GE Healthcare, Horizon Discovery Ltd, Agilent Technologies, Genscript, Kaneka Eurogentec SA, Nitto Denko Avecia, Integrated DNA Technologies, Inc., BioAutomation, LGC Biosearch Technologies, Sarepta therapeutics, Agilent Technologies and others.
Regional Market Summary
Global Oligonucleotide Synthesis Market Share by Region, 2019 (%) 
Source: World Health Organization (WHO)
The market in the Americas is expected to dominate the global oligonucleotide synthesis market due to the existence of better health care infrastructure and increasing usage of oligonucleotides by pharmaceutical companies of the region and many strategic collaborations among the players in the market. For instance, CordenPharma International, in June 2019, signed a strategic collaboration with GE Healthcare for the development of an end-to-end oligonucleotide-based drug discovery solution.
The market in Europe registers considerable growth, which can be attributed to the presence of a well-established healthcare system and increasing initiatives by government bodies for the development of novel treatment options and is estimated to provide the market with high growth potential. The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to the increasing patient awareness and increasing government initiatives for healthcare reforms. The market in the Middle East & Africa is projected to account for the least share of the global market due to low disposable income in the region.
Global Oligonucleotide Synthesis Market, by Product
- Oligonucleotide
- Column-based oligos
- Array-based oligos
- Reagents
- Equipment
Global Oligonucleotide Synthesis Market, by Type
- Custom Oligos
- Predesigned Oligos
Global Oligonucleotide Synthesis Market, by Application
- Therapeutic Applications
- Diagnostics
- RNAi
- Nucleic Acid Aptamers
- DNA/Antisense Oligonucleotides
- Immunotherapy
- Research
- PCR
- QPCR/RTQPCR
- Sequencing
- Gene Synthesis
- Others
Global Oligonucleotide Synthesis Market, by End User
- Hospitals
- Specialty Clinics
- Research Institutes
- Diagnostic Centers
- Others
Global Oligonucleotide Synthesis Market, by Region
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Intended Audience
- Research and development (R&D) companies
- Medical device companies
- Government research institutes
- Academic institutes and universities
- Venture capitalists
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 7.2% (2020-2027) |
| Base Year | 2019 |
| Forecast Period | 2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Type, Application, End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Thermo Fisher Scientific, Inc., Adtbio, Merck - Co., Inc., Bio-Synthesis Inc., Eurofins Genomics, GE Healthcare, Horizon Discovery Ltd, Agilent Technologies, Genscript, Kaneka Eurogentec SA, Nitto Denko Avecia, Integrated DNA Technologies, Inc., BioAutomation, LGC Biosearch Technologies, Sarepta therapeutics, Agilent Technologies |
| Key Market Opportunities | The Existence of Better health care infrastructure and increasing usage of oligonucleotides by pharmaceutical companies of the region and many strategic collaborations among the players in the market. |
| Key Market Drivers | New product launches and R&D Amongst major key Players |
Frequently Asked Questions (FAQ) :
Oligonucleotide Synthesis Market is projected grow at approximately 13.19% CAGR during the assessment period (2019-2025).
Technological advancements, rising disposable income levels of patients, huge investments from big pharmaceutical companies in oligonucleotide synthesis for drug development, CMO’s involvement in manufacturing therapeutic oligonucleotides, and wide application areas offered by the oligonucleotides.
North America holds the largest share in the Global Oligonucleotide Synthesis Market, followed by Europe and the Asia Pacific, respectively.
GE Healthcare (U.S.), Integrated DNA Technologies, Inc. (U.S), Agilent Technologies Inc. (U.S.), Bioautomation Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eurofins Genomics (Germany), L.G.C Biosearch Technologies (U.S.), Nitto Denko Avecia Inc. (Japan), and Eurogentec S.A (Belgium), are some of the major players operating in the oligonucleotide synthesis market.
Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global oligonucleotide synthesis market adopt to gain a larger competitive advantage.
